Wellington Management Group LLP Akero Therapeutics, Inc. Transaction History
Wellington Management Group LLP
- $529 Billion
- Q2 2025
A detailed history of Wellington Management Group LLP transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 3,409,946 shares of AKRO stock, worth $164 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,409,946
Previous 5,936,240
42.56%
Holding current value
$164 Million
Previous $240 Million
24.28%
% of portfolio
0.03%
Previous 0.05%
Shares
23 transactions
Others Institutions Holding AKRO
# of Institutions
296Shares Held
92.2MCall Options Held
1.72MPut Options Held
901K-
Janus Henderson Group PLC London, X06.74MShares$324 Million0.19% of portfolio
-
General Atlantic LLC New York, NY5.73MShares$275 Million10.64% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$268 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$263 Million4.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.53MShares$218 Million0.0% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.23B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...